Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in the management of osteosarcoma.
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L. Bielack SS, et al. Among authors: blattmann c. F1000Res. 2016 Nov 25;5:2767. doi: 10.12688/f1000research.9465.1. eCollection 2016. F1000Res. 2016. PMID: 27990273 Free PMC article. Review.
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Bielack SS, Cox MC, Nathrath M, Apel K, Blattmann C, Holl T, Jenewein R, Klenk U, Klothaki P, Müller-Abt P, Ortega-Lawerenz S, Reynolds M, Scheer M, Simon-Klingenstein K, Stegmaier S, Tupper R, Vokuhl C, von Kalle T. Bielack SS, et al. Among authors: blattmann c. Ann Oncol. 2019 Nov 1;30(Suppl_8):viii31-viii35. doi: 10.1093/annonc/mdz382. Ann Oncol. 2019. PMID: 31738425 Free PMC article.
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
Bielack SS, Cox MC, Nathrath M, Apel K, Blattmann C, Holl T, Jenewein R, Klenk U, Klothaki P, Müller-Abt P, Ortega-Lawerenz S, Reynolds M, Scheer M, Simon-Klingenstein K, Stegmaier S, Tupper R, Vokuhl C, von Kalle T. Bielack SS, et al. Among authors: blattmann c. Ann Oncol. 2019 Nov;30 Suppl 8:viii31-viii35. doi: 10.1093/annonc/mdz382. Epub 2019 Dec 24. Ann Oncol. 2019. PMID: 32223937
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L, Apice G, Heydrich BN, Setola E, Flörcken A, Ruggieri P, Krasniqi F, Hofmann-Wackersreuther G, Casali P, Reichardt P, Smeland S. Hompland I, et al. Among authors: blattmann c. Eur J Cancer. 2021 Jul;151:150-158. doi: 10.1016/j.ejca.2021.04.017. Epub 2021 May 11. Eur J Cancer. 2021. PMID: 33990016 Free article.
Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
Kube SJ, Blattmann C, Bielack SS, Kager L, Kaatsch P, Kühne T, Sorg B, Kevric M, Jabar S, Hallmen E, Sparber-Sauer M, Klingebiel T, Koscielniak E, Dirksen U, Hecker-Nolting S, Gerß JWO. Kube SJ, et al. Among authors: blattmann c. Cancer. 2022 May 1;128(9):1787-1800. doi: 10.1002/cncr.34110. Epub 2022 Feb 23. Cancer. 2022. PMID: 35195899 Free article.
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Stegmaier S, Sparber-Sauer M, Aakcha-Rudel E, Münch P, Reeh T, Feuchtgruber S, Hallmen E, Blattmann C, Bielack S, Klingebiel T, Koscielniak E. Stegmaier S, et al. Among authors: blattmann c. Pediatr Blood Cancer. 2022 Sep;69(9):e29652. doi: 10.1002/pbc.29652. Epub 2022 Mar 26. Pediatr Blood Cancer. 2022. PMID: 35338758
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Blattmann C, Borkhardt A, Csóka M, Hassenpflug W, Kabíčková E, Kager L, Kessler T, Kratz C, Kühne T, Kevric M, Lehrnbecher T, Mayer-Steinacker R, Mettmann V, Metzler M, Reichardt P, Rossig C, Sorg B, von Luettichau I, Windhager R, Hecker-Nolting S. Bielack SS, et al. Among authors: blattmann c. Eur J Cancer. 2022 Nov;176:50-57. doi: 10.1016/j.ejca.2022.09.007. Epub 2022 Sep 30. Eur J Cancer. 2022. PMID: 36191386
50 results